Developing and validating a machine learning model to predict multidrug-resistant Klebsiella pneumoniae-related

Shengnan Pan1, Ting Shi2, Jinling Ji1

  • 1Department of Medical Laboratory, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

Frontiers in Immunology
|January 27, 2025
PubMed
Abstract

Insights

A new machine learning model accurately predicts septic shock risk in patients with multidrug-resistant Klebsiella pneumoniae infections. This tool aids early intervention for better patient outcomes.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Machine Learning in Healthcare

Background:

  • Multidrug-resistant Klebsiella pneumoniae (MDR-KP) infections are a major global health concern.
  • Septic shock from MDR-KP has a high mortality rate, necessitating early risk stratification.
  • Existing prediction methods for MDR-KP-associated septic shock require enhancement.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting MDR-KP-associated septic shock risk.
  • To enable early identification of high-risk patients for timely interventions.
  • To improve clinical decision-making in managing MDR-KP infections.

Main Methods:

  • Retrospective analysis of 1,385 patients with MDR-KP infections.
  • Feature selection using LASSO regression and Boruta algorithm.
  • Evaluation of seven machine learning algorithms, selecting logistic regression for its performance and robustness.

Main Results:

  • The incidence of MDR-KP-associated septic shock was 16.32%.
  • Key predictors identified: procalcitonin, sepsis, acute kidney injury, intra-abdominal infection, vasoactive medications, ventilator weaning failure, and mechanical ventilation.
  • The logistic regression model achieved high predictive performance (AUC 0.906 training, 0.865 validation) with robust calibration.

Conclusions:

  • A validated, high-performing predictive model for MDR-KP-associated septic shock has been developed.
  • The model serves as a valuable tool for early clinical decision-making.
  • Further prospective, multi-center studies are recommended to confirm clinical applicability.